Schneider Electric Bulgaria opens geothermal energy system
Most Sofia bourse indices tick higher, Shelly Group leads gainers
Romanian stock indices turn green, TTS shines
Ljubljana stock indices go down, Cinkarna Celje paces decliners
Romania’s Orsova shipyard in 2.6 mln euro deal with Dutch client
Dec 04, 2017 15:29 EEST
SOFIA (Bulgaria), December 4 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Monday its sales revenue rose by an annual 12% in the 11 months through November, as exports increased by 21%.
On the domestic market, the company’s sales fell 1% year-on-year in January-November, Sopharma said in a bourse filing without providing figures of the value of its sales.
In November alone, Sopharma’s sales revenue rose 11% year-on-year.
Sopharma, Bulgaria's biggest pharmaceuticals producer, has subsidiaries in Moldova, Russia, Serbia, Belarus, Poland, Latvia, Lithuania, Ukraine and Kazakhstan.
In April, Sopharma acquired a 51% stake in Moldova’s drug distributor RAP Pharma International for an undisclosed price.
As at 1305 CET on Monday, Sopharma shares traded 0.33% higher at 4.294 levs ($2.6/2.2 euro).
(1 euro=1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options